Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

610 ARTÍCULOS , VIENDO DEL 451 AL 465

Interim analysis of all-case post-marketing surveillance study in Japan: lecanemab in patients with early Alzheimer's disease

Iwata A, Sakata Y, Koizumi K, Endo A, Kuang W, Sumitomo K, Ishii M.

J Prev Alzheimers Dis. 2026 May;13(5):100541. doi: 10.1016/j.tjpad.2026.100541. Epub 2026 Mar 17.

[Preventing dementia in an ageing society]

Steininger S, Xepapadakos F.

Ther Umsch. 2026 Feb;83(1):38-44. doi: 10.23785/TU.2026.01.007.

Immersive Technologies for Cognitive Rehabilitation in Dementia and Mild Cognitive Impairment: Systematic Review

Konecny J, Lanza G, Buono S, Ferri R, Luca A, Martinek R, Musso S, Palmigiano A, Prauzkova B, Quercia A, Rundo F, Subramanian RA, Serretti A, Prauzek M.

J Med Internet Res. 2026 Mar 18;28:e84349. doi: 10.2196/84349.

Identifying targets at the blood-brain barrier for treating vascular cognitive impairment and dementia

Akif A, Nguyen TTM, Hao BL, Jiang J, Li X, Fan Y, Hao J.

Expert Opin Ther Targets. 2026 May;30(5):499-511. doi: 10.1080/14728222.2026.2671696. Epub 2026 May 12.

Effects of different dietary restriction regimens on cognitive function and pathological markers in Alzheimer's disease mouse models: A systematic review and meta-analysis

Sun L, Xu X, Wang Z, Meng Y, Li Y, Hou Y, Gao X, Cui H, Li Y.

Neurosci Biobehav Rev. 2026 May;184:106601. doi: 10.1016/j.neubiorev.2026.106601. Epub 2026 Feb 8.

Treatment of Hypothyroidism That Contains Liothyronine is Associated With Reduced Risk of Dementia and Mortality

Beltrão FEL, Carvalhal G, Meneghini V, Matos DAR, Beltrão DCA, Andrade BARM, Beltrão FNL, Ramos HE, Ribeiro MO, Golovko G, Ettleson MD, Bianco AC.

J Clin Endocrinol Metab. 2026 Jan 21;111(2):561-571. doi: 10.1210/clinem/dgaf367.

Longitudinal changes in triglyceride-glucose index and the risk of incident dementia: a prospective cohort study

Ge T, Ding Y, Yan M, Zhao M, Hailili G, Wu M, Shen J, Liu X, Ma Y, Zhou D, Yuan C.

J Gerontol A Biol Sci Med Sci. 2026 Jan 2;81(1):glaf237. doi: 10.1093/gerona/glaf237.

Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study

da Silva AMP, Januário Campos Cardoso L, Batista S, Gonçalves OR, Paranhos T, Teixeira IPS, Guimarães PD, Espinosa Franco B, Cal H, Salles JEN, Perry G, Høilund-Carlsen PF, Santos DH.

J Diabetes Complications. 2026 May;40(5):109306. doi: 10.1016/j.jdiacomp.2026.109306. Epub 2026 Feb 25.

Incidence and prevalence of vascular cognitive impairment in China: a systematic review and meta-analysis

Liang SZ, Li S, Guan A, Xu R, Wei M, Wang Y, Shen W, Jiang Y, Zhang T, Cui M.

Stroke Vasc Neurol. 2026 Apr 27;11(2):137-147. doi: 10.1136/svn-2025-004436.

Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia

Cribb L, Moreno-Betancur M, Pase MP, Wolfe R, Britt C, Zhou Z, Shah RC, Rance G, Sheets KM, Chong TT, Woods RL, Murray AM, Owen A, Ryan J.

Neurology. 2026 Feb 10;106(3):e214572. doi: 10.1212/WNL.0000000000214572. Epub 2026 Jan 14.

Vascular contribution to cognitive impairment and dementia (VCID): proceedings of 2025 workshop of the Jackson Laboratory

Anwer M, Poliakova T, Albanus RD, Bhuiyan MIH, Brickman AM, Chaudhuri S, Cuddy L, Eisenbaum M, Foley K, Gould DB, Hall C, Iadecola C, Marola O, Norris CM, Reagan A, Schneider J, Wilcock D, Xu I, Yang A, Howell G, Wellington CL.

Mamm Genome. 2026 Mar 14;37(1):44. doi: 10.1007/s00335-026-10210-x.

Evaluating MRI correlates of lifestyle-based dementia risk reduction: Results from the AgeWell.de imaging study

Zülke AE, Beyer F, Luppa M, Mildner T, Frese T, Gensichen J, Kaduszkiewicz H, Czock D, König HH, Wiese B, Hoffmann W, Thyrian JR, Villringer A, Riedel-Heller SG, Witte AV.

J Alzheimers Dis. 2026 Mar;110(1):258-270. doi: 10.1177/13872877251414423. Epub 2026 Jan 13.

Hypertension as a Major Risk Factor in Alzheimer's Disease: Mechanisms, Interactions and Therapeutic Perspectives

Jiang E, Ullah S, Waheed I, Han J, Zhang X.

Clin Interv Aging. 2026 Mar 7;21:585864. doi: 10.2147/CIA.S585864. eCollection 2026.

Patterns and Trajectories of Behavioral and Neuropsychiatric Symptoms in Frontotemporal Dementia and Primary Progressive Aphasia

Marth L, Martinez-Murcia FJ, Górriz-Sáez JM, Denecke J, Ewers M, Prix C, Stockbauer AC, Bernhardt AM, Wagemann O, Wlasich E, Kustermann J, Peters O, Hellmann-Regen J, Droste Zu Senden L, Priller J, Spruth EJ, Spottke A, Asperger H, Schroeck F, Gamez A, Schneider A, Fliessbach K, Dinter E, Linn J, Günther R, Wiltfang J, Schott BH, Bähr M, Zerr I, Flöel A, Malinowski R, Buerger K, Janowitz D, Duzel E, Glanz W, Lüsebrink F, Teipel SJ, Kilimann I, Prudlo J, Hermann A, Synofzik M, Mengel D, Beichert L, Müller D, Petzold GC, Yakupov R, Hetzer S, Dechent P, Scheffler K, Schönecker S, Levin J.

Neurology. 2026 Feb 24;106(4):e214510. doi: 10.1212/WNL.0000000000214510. Epub 2026 Jan 27.

[Polypharmacy in patients with neuropsychiatric symptoms]

Schnieder M, von Arnim CAF.

Inn Med (Heidelb). 2026 Mar;67(3):289-294. doi: 10.1007/s00108-025-02049-2. Epub 2026 Jan 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias